Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06785324 · ClinicalTrials.gov registry record · NA

Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)

A NA study of B-ALL and B-cell Acute Lymphoblastic Leukemia (B-ALL), sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06785324: Recruiting NA study of B-ALL and B-cell Acute Lymphoblastic Leukemia (B-ALL), sponsored by University of Chicago.

NCT06785324 is a NA study of B-ALL and B-cell Acute Lymphoblastic Leukemia (B-ALL) that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 20 participants, below the 85-participant average among 7 other B-ALL trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06785324, a NA study of B-ALL and B-cell Acute Lymphoblastic Leukemia (B-ALL), is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This clinical trial aims to assess the effect of nutrition and exercise on muscle and adiposity in adults with Philadelphia Chromosome (Ph) Negative B-ALL undergoing inpatient induction therapy. Participants will take part in 2 different interventions: * Nutrition Intervention * Physical Exercise Intervention All subjects will be provided with a wearable electronic activity monitor (FitBit®) to assist in recording activity levels in minutes of activity.

Primary Outcome

Percentage of eligible patients that consent to trial.

Conditions Studied

B-ALL B-cell Acute Lymphoblastic Leukemia (B-ALL) Philadelphia Chromosome Negative

Interventions

  • BEHAVIORAL Nutrition Intervention
  • BEHAVIORAL Exercise intervention

Study Locations (1)

Illinois

  • University of Chicago Medicine Comprehensive Cancer Center - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-05-12
Est. Completion 2027-11-06
Phase NA
University of Chicago

796 total trials

What NCT06785324 shows while recruiting

NCT06785324 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 85-participant average among 7 other B-ALL trials with a reported enrollment target (76% lower).

The record links to 3 conditions, with B-ALL appearing as the primary indexed condition, and to 2 interventions - of which Nutrition Intervention is the first listed.

NCT06785324 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06785324 about?

NCT06785324 is a clinical study titled "Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)". This clinical trial aims to assess the effect of nutrition and exercise on muscle and adiposity in adults with Philadelphia Chromosome (Ph) Negative B-ALL undergoing inpatient induction therapy. Participants will take part in 2 different interventions: * Nutrition Intervention * Physical Exercise ...

What is the current status of trial NCT06785324?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-05-12. Estimated completion is 2027-11-06.

What conditions does trial NCT06785324 study?

This clinical trial studies the following conditions: B-ALL, B-cell Acute Lymphoblastic Leukemia (B-ALL), Philadelphia Chromosome Negative.

What interventions are being tested in trial NCT06785324?

The interventions under investigation include: Nutrition Intervention (BEHAVIORAL), Exercise intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06785324?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06785324 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for B-ALL

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06785324

Source: ClinicalTrials.gov NCT06785324, the US trial registry maintained by the National Library of Medicine. NCT06785324 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.